Pfizer Projects $33 Billion in COVID Vaccine Revenues, Driven by Boosters and Vaccines for Kids

Pfizer Projects $33 Billion in COVID Vaccine Revenues, Driven by Boosters and Vaccines for Kids Pfizer hiked its projections for COVID vaccine revenues, telling investors this week it expects booster shots, a vaccine targeting the Delta variant and anticipated authorization of its vaccines for children as young as 6 months will drive revenues higher by
The post Pfizer Projects $33 Billion in COVID Vaccine Revenues, Driven by Boosters and Vaccines for Kids appeared first on Truth Comes to Light.